Biopharmaceutical Excipients Market (By Product: Solubilizers& Surfactants/Emulsifiers [Triglycerides, Esters, Others], Polyols [Mannitol, Sorbitol, Others], Carbohydrates [Sucrose, Dextrose, Starch, Others], Specialty Biopharmaceutical Excipients/Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
       1.1.1. Definition of Biopharmaceutical Excipients
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Biopharmaceutical Excipients Market By Product
                 1.2.2.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison By Product (2015-2026)
                 1.2.2.2. Global Biopharmaceutical Excipients Market Revenue Share By Product in 2017
                 1.2.2.3. Solubilizers& Surfactants/Emulsifiers
                 1.2.2.4. Polyols
                 1.2.2.5. Carbohydrates
                 1.2.2.6. Specialty Biopharmaceutical Excipients
                 1.2.2.7. Others
       1.2.3. Biopharmaceutical Excipients Market by Geography
                 1.2.3.1. Global Biopharmaceutical Excipients Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.3.2. North America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
                 1.2.3.3. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
                 1.2.3.4. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
                 1.2.3.5. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
                 1.2.3.6. Middle East and Africa (MEA) Biopharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Biopharmaceutical Excipients Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Biopharmaceutical Excipients Major Manufacturers in 2017

CHAPTER 4. BIOPHARMACEUTICAL EXCIPIENTS MARKET BY PRODUCT

4.1. Global Biopharmaceutical Excipients Revenue By Product
4.2. Solubilizers& Surfactants/Emulsifiers
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Polyols
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Carbohydrates
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Specialty Biopharmaceutical Excipients
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

5.1. North America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
       5.3.1. U.S. Biopharmaceutical Excipients Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
       5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
       5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

6.1. Europe Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
       6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
       6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
       6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
       6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
       6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

7.1. Asia-Pacific Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
       7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
       7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
       7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
       7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
       7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
       7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

8.1. Latin America Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
       8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
       8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
       8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

9.1. Middle East Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
       9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
       9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
       9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY

10.1. Africa Biopharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Biopharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
         10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
         10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
         10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. BASF SE
         11.1.1. Company Snapshot
         11.1.2. Overview
         11.1.3. Financial Overview
         11.1.4. Product Portfolio
         11.1.5. Key Developments
         11.1.6. Strategies
11.2. ABITEC Corp.
         11.2.1. Company Snapshot
         11.2.2. Overview
         11.2.3. Financial Overview
         11.2.4. Product Portfolio
         11.2.5. Key Developments
         11.2.6. Strategies
11.3. Spectrum Chemical Manufacturing Corp
         11.3.1. Company Snapshot
         11.3.2. Overview
         11.3.3. Financial Overview
         11.3.4. Product Portfolio
         11.3.5. Key Developments
         11.3.6. Strategies
11.4. Signet Chemical Corporation Pvt. Ltd.
         11.4.1. Company Snapshot
         11.4.2. Overview
         11.4.3. Financial Overview
         11.4.4. Product Portfolio
         11.4.5. Key Developments
         11.4.6. Strategies
11.5. Pharmonix Biological Pvt. Ltd.
         11.5.1. Company Snapshot
         11.5.2. Overview
         11.5.3. Financial Overview
         11.5.4. Product Portfolio
         11.5.5. Key Developments
         11.5.6. Strategies
11.6. Roquette
         11.6.1. Company Snapshot
         11.6.2. Overview
         11.6.3. Financial Overview
         11.6.4. Product Portfolio
         11.6.5. Key Developments
         11.6.6. Strategies
11.7. SPI Pharma
         11.7.1. Company Snapshot
         11.7.2. Overview
         11.7.3. Financial Overview
         11.7.4. Product Portfolio
         11.7.5. Key Developments
         11.7.6. Strategies
11.8. Sigachi Industries Pvt. Ltd.
         11.8.1. Company Snapshot
         11.8.2. Overview
         11.8.3. Financial Overview
         11.8.4. Product Portfolio
         11.8.5. Key Developments
         11.8.6. Strategies
11.9. IMCD
         11.9.1. Company Snapshot
         11.9.2. Overview
         11.9.3. Financial Overview
         11.9.4. Product Portfolio
         11.9.5. Key Developments
         11.9.6. Strategies
11.10. Meggle AG
          11.10.1. Company Snapshot
          11.10.2. Overview
          11.10.3. Financial Overview
          11.10.4. Product Portfolio
          11.10.5. Key Developments
          11.10.6. Strategies
11.11. Clariant
          11.11.1. Company Snapshot
          11.11.2. Overview
          11.11.3. Financial Overview
          11.11.4. Product Portfolio
          11.11.5. Key Developments
          11.11.6. Strategies
11.12. Colorcon, Inc.
          11.12.1. Company Snapshot
          11.12.2. Overview
          11.12.3. Financial Overview
          11.12.4. Product Portfolio
          11.12.5. Key Developments
          11.12.6. Strategies
11.13. DFE Pharma
          11.13.1. Company Snapshot
          11.13.2. Overview
          11.13.3. Financial Overview
          11.13.4. Product Portfolio
          11.13.5. Key Developments
          11.13.6. Strategies
11.14. Others
          11.14.1. Company Snapshot
          11.14.2. Overview
          11.14.3. Financial Overview
          11.14.4. Product Portfolio
          11.14.5. Key Developments
          11.14.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
         12.1.1. Initial Data Search
         12.1.2. Secondary Research
         12.1.3. Primary Research
12.2. Assumptions and Scope


Cart Summary